Saliogen Therapeutics, Inc.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Saliogen Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2022).
SEC Form D · Apr 2022
The industry group it chose in its notices: Biotechnology.
SEC Form D · Apr 2022
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Saliogen Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Joseph Higgins | Executive officer | Apr 2022 |
| Raymond Tabibiazar | Executive officer | Apr 2022 |
| Craig Gordon | Director | Apr 2022 |
| Joseph Higgins | Director | Apr 2022 |
| Raymond Tabibiazar | Director | Apr 2022 |
| Sean Stalfort | Director | Apr 2022 |
| Sukumar Nagendran | While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proce | Apr 2022 |